SOSTDC1
Sclerostin domain-containing protein 1
Also known as: DAND7, DKFZp564D206, SOSD1_HUMAN, USAG1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6X4U4
- Gene
- SOSTDC1
- Ensembl
- ENSG00000171243
- Chromosome
- 7
- Canonical length
- 206 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
This gene is a member of the sclerostin family and encodes an N-glycosylated, secreted protein with a C-terminal cystine knot-like domain. This protein functions as a bone morphogenetic protein (BMP) antagonist. Specifically, it directly associates with BMPs, prohibiting them from binding their receptors, thereby regulating BMP signaling during cellular proliferation, differentiation, and programmed cell death. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
206 residues, UniProt reviewed canonical sequence.
>Q6X4U4|SOSTDC1
1 MLPPAIHFYL LPLACILMKS CLAFKNDATE ILYSHVVKPV PAHPSSNSTL NQARNGGRHF
61 SNTGLDRNTR VQVGCRELRS TKYISDGQCT SISPLKELVC AGECLPLPVL PNWIGGGYGT
121 KYWSRRSSQE WRCVNDKTRT QRIQLQCQDG STRTYKITVV TACKCKRYTR QHNESSHNFE
181 SMSPAKPVQH HRERKRASKS SKHSMSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SOSTDC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 233 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 233 nTPM
- stomach: 57 nTPM
- lung: 37 nTPM
- kidney: 21 nTPM
- breast: 17 nTPM
- skin: 16 nTPM
Single-cell type
- early spermatids: 22 nCPM
- late primary spermatocytes: 9.1 nCPM
- proximal tubule cells: 4.1 nCPM
- loop of henle epithelial cells: 3.7 nCPM
- breast lactating cells: 1.9 nCPM
- mucous neck cells: 0.8 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 248 nTPM
- hippocampal formation: 9 nTPM
- cerebral cortex: 8.7 nTPM
- basal ganglia: 7.2 nTPM
- hypothalamus: 5.8 nTPM
- white matter: 5.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0.16
- gnomAD missense Z
- 0.66
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- canonical Wnt signaling pathway
- epithelial cell fate commitment
- hair follicle morphogenesis
- negative regulation of BMP signaling pathway
- negative regulation of canonical Wnt signaling pathway
- negative regulation of cell fate commitment
- negative regulation of determination of dorsal identity
- negative regulation of myoblast differentiation
- negative regulation of Wnt signaling pathway
- odontogenesis of dentin-containing tooth
- pattern specification process
- mammary gland bud morphogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SOSTDC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SOSTDC1 as an antibody target. Whether an autoantibody or antibody against SOSTDC1 could matter depends on whether native SOSTDC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SOSTDC1 is annotated as secreted, so native SOSTDC1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label SOSTDC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...